Viewing nowCombinationTelmisartan/Amlodipine Dual Tablets 40/10 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
LightPharmTech Co., Ltd.

MFDS item code 201903427 · Approved 2019.05.27 · Insurance code 690301190
Treatment of essential hypertension not controlled with monotherapy
This medication is for patients with essential hypertension who have not achieved adequate blood pressure control with either amlodipine or telmisartan alone. In such cases, alternative treatment methods may be necessary for more effective blood pressure management compared to using one of the medications alone. Amlodipine primarily lowers blood pressure by dilating blood vessels, while telmisartan controls blood pressure by blocking the action of hormones that raise blood pressure. For those whose blood pressure remains inadequately controlled with monotherapy, combination therapy or other medication adjustments might be considered. Therefore, it is crucial to consult with healthcare professionals to establish an appropriate treatment plan for effectively managing essential hypertension. These medications are used in the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dosage adjustment is necessary for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to initiate treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be administered this medication with caution’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a lower dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medication have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication may cause serious side effects to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by women who are pregnant or may become pregnant. Before taking this medication, it is essential to check for allergies to the ingredients or similar class of drugs. Patients with severely impaired liver or kidney function, heart issues, or low blood pressure should avoid taking this medication or exercise caution. Patients with primary aldosteronism, heart valve disease, obstructive hypertrophic cardiomyopathy, gastrointestinal disorders, renovascular hypertension, those undergoing dialysis, elderly patients, and others should be extra cautious when using this medication. Various side effects such as dizziness, peripheral edema, headache, visual disturbances, low blood pressure, orthostatic hypotension, gastrointestinal disturbances, liver function abnormalities, and skin rashes may occur, so if any unusual symptoms arise during treatment, you should consult healthcare professionals immediately. Immediate treatment is required if blood pressure drops too low or severe dizziness or fainting occurs, and periodic blood tests to check kidney function and electrolyte levels are important. This medication may interact with other medications, so inform your healthcare provider of any currently taken medications, and concomitant use with grapefruit juice is not recommended. This medication should not be taken during pregnancy or while breastfeeding, and breastfeeding women are advised to avoid using it. Safety and efficacy in pediatric patients have not been sufficiently established, so it is not recommended for children. For the elderly, it is preferable to start with a low dose and gradually increase the dosage. In the case of overdose, symptoms like low blood pressure, dizziness, and changes in heart rate may occur, and appropriate treatment should be sought immediately from a medical facility. This medication should be stored out of reach of children and should be kept in its original packaging to maintain product quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Furthermore, it is important to keep it at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness.
White and light gray, double convex, oval-shaped tablets
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
LightPharmTech Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.